Anti-Donor Regulatory T-Cell Therapy in Adult-to-Adult Living Donor Liver Transplantation: A Case Report.

[1]  N. Rogers,et al.  Transplant Tolerance Induction: Insights From the Liver , 2020, Frontiers in Immunology.

[2]  M. Sykes,et al.  Transient Mixed Chimerism With Nonmyeloablative Conditioning Does Not Induce Liver Allograft Tolerance in Nonhuman Primates. , 2020, Transplantation.

[3]  S. Nundy,et al.  De Novo Malignancy After Living Donor Liver Transplantation: A Large Volume Experience. , 2020, Journal of clinical and experimental hepatology.

[4]  S. Todo,et al.  Anti-donor regulatory T cell therapy in liver transplantation. , 2017, Human immunology.

[5]  F. Fujita,et al.  Relationship between immune function recovery and infectious complications in patients following living donor liver transplantation , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[6]  S. Todo,et al.  A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation , 2016, Hepatology.

[7]  T. Kuroki,et al.  Does the development of chronic kidney disease and acute kidney injury affect the prognosis after living donor liver transplantation? , 2016, Clinical transplantation.

[8]  F. Fujita,et al.  CD4 T lymphocyte counts in patients undergoing splenectomy during living donor liver transplantation. , 2016, Transplant immunology.

[9]  T. Kuroki,et al.  Technical refinement of hepatic vein reconstruction in living donor liver transplantation using left liver graft. , 2015, Annals of transplantation.

[10]  K. Hasegawa,et al.  New-onset diabetes mellitus developing in Asian adult living donor liver transplant recipients: a single-center experience , 2013, Journal of hepato-biliary-pancreatic sciences.

[11]  H. Ohdan,et al.  Optimization of immunosuppressive therapy based on a multiparametric mixed lymphocyte reaction assay reduces infectious complications and mortality in living donor liver transplant recipients. , 2012, Transplantation proceedings.

[12]  S. Uemoto,et al.  Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CD4+CD25+FoxP3+ T regulatory cells , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[13]  M. Levings,et al.  ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells. , 2009, Blood.

[14]  Xiao-ping Chen,et al.  Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection. , 2009, Surgery.

[15]  M. Sayegh,et al.  A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells. , 2006, Journal of the American Society of Nephrology : JASN.

[16]  T. Asahara,et al.  Multiparameter Flow Cytometric Approach for Simultaneous Evaluation of Proliferation and Cytokine‐Secreting Activity in T Cells Responding to Allo‐stimulation , 2004, Immunological investigations.

[17]  S. Uemoto,et al.  WEANING OF IMMUNOSUPPRESSION IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS1 , 2001, Transplantation.

[18]  S. Uemoto,et al.  Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance. , 2001, Transplant immunology.

[19]  L. Naldini,et al.  Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.